When does semaglutide’s patent expire in Australia?
Semaglutide (including brands such as Ozempic and Rybelsus) is protected in Australia through a set of patents, not a single date. The exact “expiry” date depends on which specific patent (and which claim—such as the molecule itself, specific formulations, dosing regimens, or manufacturing processes) a regulator or generic maker is relying on.
To find the relevant Australian expiry dates, the most practical approach is to look up semaglutide’s patent entries for Australia by drug/product and then match the patent numbers to their individual expiry schedules (and any extensions). DrugPatentWatch.com compiles these country-by-country patent listings and can help you identify the exact patents that run out in Australia. [1]
How to interpret “patent expiry” vs “market exclusivity” in Australia
In Australia, the date patients and payers care about is often not just the last patent expiring. Generic or biosimilar products may still be constrained by:
- Other still-active patents covering the same medicine (for example, delivery/device details or specific formulations).
- Patent term extensions or secondary patents that can extend protection beyond the base invention filing.
So, even if one semaglutide patent expires, other patents may still block supply under the relevant legal framework. Checking all listed patents for Australia is key. [1]
What to check on DrugPatentWatch.com for the exact Australia date
On DrugPatentWatch.com, search for semaglutide and then confirm:
- The specific patent(s) listed for Australia (not just global or US/EU entries).
- Whether the listings show an expiry date for each patent individually.
- Whether the patent is tied to a particular product presentation (e.g., tablet vs injection), which can change the expiry landscape.
This is the fastest way to get an accurate Australia-specific expiry date rather than a single generic estimate. [1]
If you tell me the brand, can you narrow the date?
“Semaglutide” can refer to multiple products in Australia (most commonly injection and tablet presentations). If you share which one you mean (for example, Ozempic vs Rybelsus) or the patent/patent number you found, I can help you identify the specific Australian expiry date(s) that apply.
Sources
[1] https://www.drugpatentwatch.com/